HomeCompareTABD vs JNJ

TABD vs JNJ: Dividend Comparison 2026

TABD yields 0.98% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TABD wins by $1.0K in total portfolio value
10 years
TABD
TABD
● Live price
0.98%
Share price
$24.92
Annual div
$0.24
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$104.48
Full TABD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TABD vs JNJ

📍 TABD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTABDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TABD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TABD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TABD
Annual income on $10K today (after 15% tax)
$83.33/yr
After 10yr DRIP, annual income (after tax)
$88.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $614.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TABD + JNJ for your $10,000?

TABD: 50%JNJ: 50%
100% JNJ50/50100% TABD
Portfolio after 10yr
$20.5K
Annual income
$466.13/yr
Blended yield
2.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TABD
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TABD buys
0
JNJ buys
0
No recent congressional trades found for TABD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTABDJNJ
Forward yield0.98%3.36%
Annual dividend / share$0.24$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.1K$20.0K
Annual income after 10y$104.48$827.78
Total dividends collected$1.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TABD vs JNJ ($10,000, DRIP)

YearTABD PortfolioTABD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,798$98.03$10,676$355.77+$122.00TABD
2$11,653$98.93$11,407$389.39+$246.00TABD
3$12,568$99.78$12,198$426.53+$370.00TABD
4$13,549$100.58$13,056$467.62+$493.00TABD
5$14,598$101.33$13,987$513.12+$611.00TABD
6$15,722$102.04$14,998$563.56+$724.00TABD
7$16,926$102.70$16,098$619.52+$828.00TABD
8$18,214$103.33$17,295$681.69+$919.00TABD
9$19,593$103.92$18,599$750.82+$994.00TABD
10$21,069$104.48$20,022$827.78+$1.0KTABD

TABD vs JNJ: Complete Analysis 2026

TABDStock

TABD is structured as a broad fixed income fund that allocates primarily to bonds and bond-like instruments across government, corporate, securitized, and structured credit markets. The portfolio emphasizes investment grade securities, while allowing limited exposure to below-investment-grade debt, emerging markets, and non-US issuers. Duration is not managed to a specific target, giving the portfolio flexibility to adjust interest rate sensitivity across market environments. Derivatives may be used selectively to manage exposure, adjust duration, or alter risk characteristics. Portfolio positioning is informed by a combination of macroeconomic assessment and security-level analysis, with flexibility across sectors, maturities, and credit profiles in pursuit of total return through income and capital appreciation.

Full TABD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TABD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TABD vs SCHDTABD vs JEPITABD vs OTABD vs KOTABD vs MAINTABD vs ABBVTABD vs MRKTABD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.